[Health care to HIV/AIDS patients in Brazil].
This study was intended to assess care provided to those living with HIV/AIDS in Brazil and the Brazilian Unified Health System (SUS) capacity of delivering interventions to cope with the epidemic as well as to discuss the sustainability of the Brazilian initiative of providing universal free access to antiretrovirals (ARVs). Original data from a study comprising 119 respondents on the potential capacity of delivering a prospective HIV vaccine in Brazil was used. Inpatient and pharmaceutical care was based on data from the SUS Hospital Information System and Drug Logistics Management Systems of the National Program for STD/AIDS. The study results indicate good performance of the Brazilian ARV Access Program but access to treatment of opportunistic infections was, however, unsatisfactory. The rates covered by SUS for AIDS hospital admissions remained very low, on average around R$700 in 2004. Health care to HIV/AIDS patients has been considered a citizen's right strongly supported by an effective joint action of the Brazilian government and civil society. The current challenges are fine monitoring of processes and program results and ensuring sustainability of universal free ARV access.
Portela
Margareth Crisóstomo
MC
Departamento de Administração e Planejamento em Saúde, Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, Rua Leopoldo Bulhões 1480 sala 724, Manguinhos, 21041-210 Rio de Janeiro, RJ, Brazil. mportela@ensp.fiocruz.br
Lotrowska
Michel
M
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000517:prevention & control; D019380:Anti-HIV Agents / Q000600:supply & distribution / Q000627:therapeutic use*; D001938:Brazil; D003695:Delivery of Health Care; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D009313:National Health Programs; D020380:Needs Assessment; D010343:Patient Admission
D019380:Anti-HIV Agents